Molecular biomarkers and histological parameters impact on survival and response to first- line systemic therapy of metastatic colorectal cancer patients
, , et
03 mars 2019
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 03 mars 2019
Pages: 85 - 95
Reçu: 30 août 2018
Accepté: 20 sept. 2018
DOI: https://doi.org/10.2478/raon-2019-0013
Mots clés
© 2019 Martina Rebersek, Tanja Mesti, Marko Boc, Janja Ocvirk, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Rebersek, Martina
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Mesti, Tanja
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Boc, Marko
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Ocvirk, Janja
Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia